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• Developing countries
– Most patients are living in areas with access to direct smear microscopy only to confirm TB 
– Culture available only in national/regional TB laboratory
• High prevalence of TB and HIV co-infected patients
– Lower sensitivity of direct smear microscopy (50%) 
– Risk of under and late TB diagnosis
– Urgent need for better diagnostic test for smear negative patients
Reasons for selecting FASTPlaqueTBTM test for evaluation
– 2 days test
– According to literature, detects 50 to 67% smear-negative culture-positive cases
– Presented by the Manufacturer as potentially suitable for district laboratory
– No multiplication of Mycobacterium tuberculosis bacilli
– To evaluate the feasibility of FASTPlaqueTBTM test in a laboratory performing in routine only 
direct smear-microscopy 
METHODS
• To evaluate the performance of FASTPlaqueTBTM test to detect tuberculosis in smear-
negative patients in a peripheral setting and high HIV prevalence context
• To evaluate the feasibility of FASTPlaqueTBTM test in a laboratory performing only 
direct smear-microscopy
• Prospective study
• Urban primary health care setting, Mathare, Nairobi city, Kenya
• Inclusion criteria
– > 15 years old 
– Cough > 2 weeks
– 3 negative smear microscopy results 
– No response to one week amoxicillin 
course 
– Abnormal chest X-ray 
– Informed consent
• Consecutive sampling
• Voluntary Counselling HIV Test 
• High contamination rate
– FASTPlaqueTBTM 95.6% (44/46)
– Culture 21.7% (10/46) 
• Modifications before to starting inclusions
– Retraining of laboratory technologists in:
• Aseptic techniques
• Autoclave use
• Working with a Laminar Flow Cabinet (LFC)
– Increase in autoclave time to compensate for local altitude 
and volumes of liquid autoclaved
– Move of LFC to a separate room with restricted access
– Maintenance of LFC by technician from South Africa
(expertise not available locally) and change of the HEPA filter
after 3 months of use 
Recruitment stopped early due to the high rate 
of FASTPlaqueTBTM unreadable
• 201 patients included
HIV status
• 35 (17.4%) negative
• 115 (57,2%) positive
• 51 (25.4%) not done
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Figure 1: FASTPlaque test principle.
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• Laboratory procedure
– Collection of 1 spot sputum specimen 
– Decontamination: NALC/NaOH followed by 
neutralization with Phosphate buffer
– Half of specimen tested locally with  
FASTPlaqueTBTM according to the 
manufacturer’s instructions 
– Half of specimen referred for culture on 
Lovenstein Jensen medium
• FASTPlaqueTBTM results
– 10 (5.0%) positive 
– 98 (48.8%) negative 
– 93 (46.3%) unreadable
• Preliminary culture results*
– Contaminated: 10/198 (5.1%)
– Positive: 32/188 (16.5%)
* 3 cultures still under process
The vast majority of contaminants were Gram 
positive bacilli
• Evaluation of procedures and working of the 
LFC
– Sterile water aseptically poured into a sterile conical tube 
and processed as a specimen
– No contamination on the resulting plate 
• LFC was working efficiently
• Aseptic techniques were good
Investigation  Investigation of of the the source  source of of contamination contamination
• Specimen collection
– Sterile water poured aseptically into a sterile conical tube 
and exposed to the air where specimens were collected 
– Tube processed as a specimen 
– Contamination of plate with gram positive bacilli
The spores were probably introduced during the collection process
Bacterial and fungal spores are very common in dust, and are 
extremely difficult to control
The decontamination process could kill all the vegetative forms of 
bacteria that could have been introduced by the dusty air, but failed to 
kill the spores
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DISCUSSION
• Inter-reader reliability
Kappa [95% CI] = 0.81 [0.76 - 0.84] 
• Test duration
– Weekly containers sterilisation: median 2.8h ((IQR* 2.5-3.1)
– Weekly reagent preparation: median 2.6h (IQR 2.3-3.1)
– Test procedure
• Decontamination (1st day): median 2.4 hours (IQR 2.1-2.5)
• 2nd day procedure: median 2.5 hours (IQR 2.3-3)
• Time between sputum collection and result
2 to 9 days because tests were performed only once a week to prevent wasting of tests and
reagents (kits of 10 tests)
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• Human resource
Intensive training of technician with no experience of working in aseptic conditions and under a LFC
• Cost within the study context
– The test costs 7€/ patient, 60% being extra-cost to the cost the FASTPLaqueTBTM test
– Upgrading the laboratory, equipement and maintenance cost 19,800€
• Main findings
– 40% unreadable results due to contamination
– 10 tests kit might not be adapted for settings with 
low activity when used only in smear-negative 
patients
– Requirement of culture level laboratory to perform 
FASTPlaqueTBTM
– Difficult and costly to upgrade peripheral laboratory 
to perform FASTPlaqueTBTM
• Human resource ability to work under aseptic conditions
• Two rooms laboratory with a separate room for the LCF
• Expensive and fragile equipment
• 24h electrical power required
• Maintenance not available locally
• Perspectives
– Modified FASTPlaqueTBTM with 
expected lower contamination currently 
under evaluation by the Manufacturer
– FASTPlaqueTBTM remains still a 
potentially interesting test considering 
the 2 days results but requires culture 
level laboratory 
– Upgrading of peripheral laboratory to 
perform culture level test might only be 
feasible in very few settings
– More R&D on new tests suitable for 
peripheral setting is a top priority
Performance of  Performance of FASTPlaqueTB FASTPlaqueTBTM TM
• N= 101 after exclusion of contaminated cultures and unreadable 
FASTPlaqueTBTM
79.4-93.8 87.9 80/91 Negative Predictive Value
18.7-81.3 50.0 5/10 Positive Predictive Value
86.8-98.1 94.9 80/85 Specificity
12.1-58.5 31.2 5/16 Sensitivity
95% Confidence interval % n/N
• Culture and FASTPlaqueTBTM contamination 
rates
• Facility, equipment, human resources 
requirements 
• Workload assessed by the duration of the test 
procedures 
• Time between specimen collection and result
• Outcomes
– Sensitivity, specificity and predictive 
values 
– Inter reader reliability
Very good agreement if Kappa test >0.80
– Feasibility criteria